Near future
Contact us
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • energia
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
July 5 2022

Coronavirus / Russia-Ukraine

Near future

News to understand, anticipate, improve the future.

No Result
View All Result

News to understand, anticipate, improve the future.

Read in:  Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Juvenescence, funds and consents for longevism

Founded in 2016, Juvenescence is the company that is creating a "longevism ecosystem" and is collecting a boat of money. Here are his plans.

Gianluca Ricciodi Gianluca Riccio
in Medicine
Share36Pin3Tweet10SendShare3ShareShare2
2 September 2019
⚪ Reads in 3 minutes
A A

Juvenescence, which is aiming to increase lifespan to 150 years soon, raised $ 100 million in its latest fundraising campaign.

Juvenescence

Founded in 2016, Juvenescence is the company that is creating a "longevism ecosystem". With world-renowned scientists, pharmacologists, machine learning experts and capable managers able to move safely in this booming biotech sector.

The latest press release from the company announces a $ 10 million loan from its founders and another $ 10 million apiece for 4 other investors. These include Grok Ventures, Mike Cannon-Brookes' investment company, and the private fund IPGL. The total raised by Juvenescence in the past 18 months is therefore $ 165 million, a figure that shows all the growth in interest in longevity medical therapies.

“Juvenescence has raised more funds than other similar companies, and it's good news for longevism. It is a reward for the skills of our team. It makes us believe even more in the opportunities we are testing in collaboration with scientists, entrepreneurs and research institutes, " says Jim mellon, one of the founders of Juvenescence.

Maybe you are also interested

World Autism Awareness Day: Progress Made

Coinbase CEO launches NewLimit, startup to extend human life

The pupils can perceive numerical information, not just light

University of Leicester designs antibody against cellular aging

“We have brought together a group of fantastic experts from around the world for our common mission to extend human life. As longevism becomes a known issue, we expect investor interest to rise. The next phase will be listing on the Juvenescence stock exchange to further accelerate its development. "

Juvenescence

12 apostles of longevism: they will become 4 (or more) evangelists

The funds raised will be used to advance the various anti-aging programs, 12 of which are undergoing clinical trials. Of these, at least 4 will be on the market between 5 and 7 years from 2019.

Among them, many carry products that slow down cellular aging. Others reverse neurodegenerative processes or destroy senescent cells. Still others replace exhausted organs and edit patient genes.

"The past six months have been really exciting for Juvenescence," says the CEO Dr. Greg Bailey. “Extraordinary medical and IT professionals have joined the team, they will help us bring our therapies to the public. This new injection of funds will give us the capital necessary to fully develop our first solutions ".

Il longevism he gets more and more interest and money. The world anti-aging market is estimated at around $ 110 billion.

A recent estimate by the Bank of America has predicted crazy growth by 2025. It will bring $ 610 billion to a market that should already begin to extend our life by that date.

tags: life extensionLifespanlongevismMachine learningmedical research
Previous post

Park assist? It was already there in the 20s

Next Post

In the iOS13 code a clue about the new Apple Glasses

COLLABORATE

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

    archive

    Have a look here:

    4253C497 A302 4CDA B4C3 C1C58EA52025
    Medicine

    Eliminating a protein could prevent heart attacks and strokes

    A protein called TRPM2 appears to be directly responsible for macrophage dysfunctions that lead to heart attacks and strokes

    Read More
    Coronavirus predictions. Li Edelkoort: it will change the face of the planet

    Coronavirus predictions. Li Edelkoort: it will change the face of the planet

    communicate with those who are dreaming in REM sleep

    A team discovers how to communicate with those who are dreaming in REM sleep

    The robotic arm of DARPA ready in 4 years.

    The robotic arm of DARPA ready in 4 years.

    Deploy, water reservoir for developing nations

    Deploy, water reservoir for developing nations

    The daily tomorrow

    Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

    Subscribe to our newsletter

    Environment
    Architecture
    Artificial intelligence
    Gadgets
    concepts
    Design

    Staff
    Archives
    Advertising
    Privacy Policy

    Medicine
    Spazio
    Robotica
    Work
    Transportation
    energia

    To contact the FuturoProssimo editorial team, write to [email protected]

    Chinese Version
    Édition Française
    Deutsche Ausgabe
    Japanese version
    English Edition
    Edição Portuguesa
    Русское издание
    Spanish edition

    This work is distributed under license Creative Commons Attribution 4.0 International.
    © 2021 Futuroprossimo

    No Result
    View All Result
    • Home
    • Tech
    • Health
    • Environment
    • Architecture
    • energia
    • Transportation
    • Spazio
    • AI
    • concepts
    • Gadgets
    • Italy Next
    • H+